No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
CVS241220C49000
- 0.69
- -0.60-46.51%
15min DelayTrading Dec 16 10:28 ET
1.02High0.68Low
1.00Open1.29Pre Close209 Volume351 Open Interest49.00Strike Price17.15KTurnover44.88%IV2.59%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry0.69Extrinsic Value100Contract SizeAmericanOptions Type0.4411Delta0.1684Gamma70.20Leverage Ratio-0.1192Theta0.0024Rho30.96Eff Leverage0.0206Vega
Intraday
- 5D
- Daily
News
Morgan Stanley Maintains CVS Health(CVS.US) With Buy Rating, Maintains Target Price $63
Morgan Stanley Sticks to Its Buy Rating for CVS Health (CVS)
Press Release: CVS Health Corporation Announces Early Results of Maximum Tender Offer and Election of Early Settlement
CVS Health Corporation Announces Early Results of Maximum Tender Offer and Election of Early Settlement
CVS Health (CVS) Stock Moves -0.42%: What You Should Know
What the Upcoming Holiday GST Relief Will Mean for Consumers